Therapeuticsmd Inc (TXMD)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할

Relative Volume:

Therapeuticsmd Inc Stock (TXMD) Company Profile

Therapeuticsmd Inc

Healthcare (1115)

561-961-1900

951 YAMATO ROAD, SUITE 220, BOCA RATON, FL

@TherapeuticsMD

최신 SEC 제출 서류

TXMD's Discussions on Twitter

TXMD을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
TXMD Therapeuticsmd Inc	2.23	25.93M	996.00K	-6.09M	-9.76M	-0.53
ZTS Zoetis Inc	124.65	55.21B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.16	51.59B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.83	43.51B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.76	37.11B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	464.93	20.32B	3.08B	1.24B	1.07B	25.61

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-08-07	다운그레이드	Jefferies	Hold → Underperform
2020-05-19	다운그레이드	JP Morgan	Overweight → Neutral
2019-12-02	개시	Guggenheim	Buy
2019-10-17	개시	H.C. Wainwright	Buy
2019-04-30	재개	Noble Capital Markets	Outperform
2018-06-15	개시	JP Morgan	Overweight
2017-09-08	개시	Morgan Stanley	Equal-Weight
2017-07-11	업그레이드	Oppenheimer	Perform → Outperform
2017-05-09	다운그레이드	Oppenheimer	Outperform → Perform
2016-11-22	재개	Jefferies	Buy
2016-11-22	개시	Oppenheimer	Outperform
2016-11-07	재개	Guggenheim	Buy
2016-04-04	개시	Goldman	Buy
2015-12-08	재확인	Jefferies	Buy
2015-12-08	재확인	Stifel	Buy
2015-09-21	재확인	Jefferies	Buy
2015-06-09	개시	Guggenheim	Buy
2014-07-08	개시	FBR Capital	Outperform
2014-04-17	재확인	Noble Financial	Buy
2014-01-28	재확인	Noble Financial	Buy

Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스

Therapeuticsmd Inc (TXMD) 재무 분석

Therapeuticsmd Inc 주식 (TXMD) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Thompson Tommy G	Director	Apr 14 '25	Buy	1.00	325	326	14,779
Walker Marlan D	Chief Executive Officer	Apr 14 '25	Buy	1.00	490	489	73,639
Walker Marlan D	Chief Executive Officer	Apr 10 '25	Buy	0.86	1,167	1,000	73,149
Walker Marlan D	Chief Executive Officer	Apr 09 '25	Buy	0.87	1,136	994	71,982
Collins Cooper C.	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	60,516
Naughton Gail K	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	8,500
Thompson Tommy G	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	14,454
Walker Marlan D	Chief Executive Officer	Feb 18 '25	Option Exercise	0.00	8,281	0	70,846

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc Stock (TXMD) Company Profile

TXMD을(를) 다른 주식과 비교

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스

Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn

Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn

Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ

Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ

Portfolio Shifts: Is TherapeuticsMD Inc stock heavily shortedMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn

Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ

TherapeuticsMD Reports Q3 2025 Financial Results - MSN

Why TherapeuticsMD Inc. stock could be next big winnerShare Buyback & Accurate Buy Signal Alerts - Улправда

Is TherapeuticsMD Inc. stock a buy for dividend growthCPI Data & Weekly Setup with ROI Potential - Улправда

Will TherapeuticsMD Inc. stock continue upward momentum2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда

Is TherapeuticsMD Inc. stock a safe haven asset2025 Performance Recap & Free Community Consensus Stock Picks - Улправда

Can TherapeuticsMD Inc. stock rebound after recent weaknessChart Signals & Smart Investment Allocation Tips - Улправда

Can TherapeuticsMD Inc. stock deliver strong Q4 earningsJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда

Chart Watch: Can TherapeuticsMD Inc. stock deliver strong Q4 earningsQuarterly Profit Report & Weekly Top Gainers Trade List - Улправда

How strong is TherapeuticsMD Inc. stock revenue growthTreasury Yields & Technical Pattern Recognition Alerts - Улправда

Analysis Recap: Why TherapeuticsMD Inc. stock could be next big winner2025 Key Lessons & Detailed Earnings Play Strategies - Улправда

Will TherapeuticsMD Inc. stock deliver long term returnsFibonacci Extensions & Easy Tools to Analyze Your Investment Risk - Улправда

EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD approves key proposals at annual meeting - MSN

TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда

Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда

MSN Money - MSN

TherapeuticsMD Earnings Notes - Trefis

Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru

How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда

Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets

TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks

TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan

Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets

29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn

With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis

TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga

TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph

Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser

Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser

Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser

Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser

TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛

Therapeuticsmd Inc (TXMD) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Therapeuticsmd Inc 주식 (TXMD) 내부자 거래

TXMD과 유사한 종목